MedTech Spectrum

Article Name Predictive Diagnostics

Immunovia to Appoint New CFO as Company Shifts Focus to U.S. Market

With plans to commercialize its pancreatic cancer test in the U.S. by late 2025, Immunovia seeks financial leadership with diagnostics expertise and global capital market experience.

24th February, 2025

Co-Diagnostics Withdraws 510(k) Submission for COVID-19 Test to Pursue Enhanced Version

Following constructive discussions with the FDA, Co-Dx shifts focus to an improved test submission, incorporating platform advancements and optimizing long-term performance.

24th February, 2025

UroMems Achieves Major Milestone in First-Ever Smart Implant Study for Female SUI Patientsv

With all female patients in its groundbreaking clinical feasibility study reaching six-month primary endpoints, UroMems' UroActive System marks a transformative step in treating stress urinary incontinence. The AI-powered smart implant, designed to enhance patient quality of life, is now paving the way for expanded adoption in the U.S. and Europe.

21st February, 2025

3Shape Celebrates 25 Years of Innovation with AI-Powered Advancements in Dental CAD Workflows

3Shape is celebrating 25 years of innovation by introducing a paradigm shift in CAD workflows for dental labs with the upcoming release of 3Shape Dental System 2024. This new software update will include a free AI-driven crown design application along with several workflow enhancements to significantly improve efficiency and digitization for dental labs. As the first employee hired at 3Shape 25 years ago, Rune Fisker, Senior Vice President of Product Strategy, reflects on the remarkable evolution of CAD/CAM technology from a visionary concept to an industry standard. He emphasizes the growing adoption of digital workflows and the necessity for lab technicians to experience the speed, automation, and convenience of the new Dental System 2024 software. Unveiled at LMT Lab Day and the upcoming IDS in Germany, 3Shape Dental System 2024 introduces several groundbreaking upgrades. Labs will now have access to AI-powered design proposals for crowns, inlays, and onlays at no additional cost with a 3Shape LabCare subscription. This feature eliminates the need for manual setup and ensures high-quality editable designs that streamline case management. The software also boosts efficiency with up to 10x faster case processing, 20x faster case reopening, and AI automation for routine tasks such as occlusal plane positioning and segmentation. Further enhancements include a seamless integration between 3Shape LMS and Dental System to reduce administrative workload and improve data accuracy. The new TRIOS ioConnect Workflow for All-on-X treatments simplifies full-arch restorations, integrating TruAbutment's ioConnect elongated abutments with 3Shape's software and intraoral scanners. Additionally, 3Shape is eliminating physical software license dongles in favor of cloud-based licensing, ensuring easier updates and real-time access to purchased software. Dental System 2024 marks a new era in digital dentistry, empowering dental labs with cutting-edge AI-driven tools, seamless integrations, and enhanced automation. By prioritizing speed, accuracy, and convenience, 3Shape continues to push the boundaries of digital innovation, allowing lab professionals to focus on delivering exceptional service to their clients.

21st February, 2025

Encore Clinical Holdings Expands Wound Care Services to Tennessee, Strengthening Leadership in Specialized Care

With its innovative, technology-driven model, Encore Wound Care extends its footprint to Tennessee, enhancing clinical outcomes, optimizing facility operations, and treating over 10,000 wounds per week across its growing service regions.

20th February, 2025

NaviFUS Leverages Taiwan’s Advanced Chip Technology to Advance Non-Invasive Brain Disorder Treatments

With groundbreaking ultrasound-based solutions for brain cancer and drug-resistant epilepsy, NaviFUS expands its global impact through strategic industry collaborations, clinical breakthroughs, and partnerships with leading healthcare innovators.

20th February, 2025

Zydus Lifesciences & Guardant Health Back India’s First Liquid Biopsy Academy to Advance Precision Oncology

LiS Academy, an independent academic forum led by top oncologists, aims to enhance awareness and adoption of liquid biopsies for personalized cancer care in India.

19th February, 2025

B. Braun Launches Emergency Department Single-Shot Nerve Block Tray to Enhance Acute Pain Management

Designed for emergency settings, the new tray features the Ultraplex® 360 Needle with advanced echogenic technology, enabling precise regional anesthesia as a safer alternative to opioids.

19th February, 2025

MASAI Trial Confirms AI-Powered Transpara® Improves Breast Cancer Detection While Reducing Radiologist Workload

Largest Randomized AI Mammography Study Shows 29% Higher Cancer Detection with 44% Less Screen-Reading Burden

18th February, 2025

NeuralCure AI Redefines Medical Research with AI-Driven Simulations, Opens Fundraising to Scale Precision Healthcare

By compressing decades of medical discoveries into a single day, NeuralCure AI’s cutting-edge platform accelerates treatment breakthroughs for complex diseases. The company launches a new funding round to expand AI-driven diagnostics and personalized medicine on a global scale.

17th February, 2025

Navi Medical Secures FDA Clearance for Neonav® Pediatric Vascular Access System

The first-of-its-kind system, designed specifically for neonatal and pediatric patients, leverages real-time ECG signal analysis to improve CVAD placement, enhance patient safety, and reduce complications, marking a major milestone in global pediatric healthcare.

17th February, 2025

Bangkok Dusit Medical Services Partners with CNN to Tackle Global Health Challenges

Collaboration aims to explore next-gen healthcare solutions through innovation and global insights.

11th February, 2025

NUS Scientists develop advanced 'Micro-Gut' Model to study Gut Microbes and Human Diseases

Breakthrough innovation enables realistic simulation of gut environments for deeper insights into microbiome-related health conditions.

11th February, 2025

The Growing Trend of Social Egg and Embryo Freezing: Empowering Women to Plan Parenthood on Their Own Terms

Dr. Kaushal Kadam, MBBS, MD, DGO and Director, Corion Fertility Clinic Pvt Ltd.

10th February, 2025

“There remains a high unmet need for new & alternative treatment options for prurigo nodularis & atopic dermatitis”

Asia-Pacific region houses some of Galderma’s fastest growing markets, where sales have fueled a strong performance. There have been multiple successes in the region in 2024 for the Swiss pharmaceutical firm, with a number of important product launches, such as Restylane VOLYME in China, Restylane EYELIGHT in Korea and Alastin in Australia. More recently, Relfydess (RelabotulinumtoxinA) was approved in Australia and Sculptra - which celebrated its 25th launch anniversary this year - was approved in China. Gerry Muhle, Galderma’s Head of Global Product Strategy, spoke to BioSpectrum Asia in detail about the company’s growth plans in 2025 and beyond.

03rd February, 2025

Madhya Pradesh Chief Minister Showcases Ujjain’s Medical Device & Pharma Park to Japanese Investors in Tokyo, Positioning MP Among India’s Leading Industrial States

Dr. Mohan Yadav discusses strategic investment opportunities with A&D Medical, highlighting Madhya Pradesh’s business-friendly policies, infrastructure incentives, and vision for advancing life sciences manufacturing in India.

29th January, 2025